 |
BIOAM
Bioam is fully dedicated to early stage capital investment in the Biotechnology business and
its applications in the healthcare, agribusiness and environment industries.
The fund was established in 2000 with the support of the following Limited Partners:
- CDC Entreprises -subsidiary of the Caisse des Dépôts group-,
- AXA Private Equity,
- the Caisse d'Epargne et de Prévoyance de Rhône-Alpes
- and three French government-funded research organization : CNRS, INRA and INSERM through
their respective technology transfer offices
Subsequently, additional industrial, institutional and financial investors contributed to the
fund, bringing the total subscriptions to €44 million. |
